Calamos Advisors LLC Makes New Investment in BlackRock Health Sciences Term Trust $BMEZ

Calamos Advisors LLC purchased a new stake in BlackRock Health Sciences Term Trust (NYSE:BMEZ) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 51,559 shares of the company’s stock, valued at approximately $740,000.

A number of other hedge funds have also modified their holdings of BMEZ. Rivernorth Capital Management LLC raised its position in shares of BlackRock Health Sciences Term Trust by 195.8% during the 4th quarter. Rivernorth Capital Management LLC now owns 648,567 shares of the company’s stock worth $9,761,000 after purchasing an additional 429,291 shares during the last quarter. Lazard Asset Management LLC acquired a new stake in BlackRock Health Sciences Term Trust during the 4th quarter valued at $5,697,000. Invesco Ltd. increased its position in BlackRock Health Sciences Term Trust by 42.7% during the third quarter. Invesco Ltd. now owns 929,121 shares of the company’s stock worth $13,398,000 after buying an additional 278,024 shares in the last quarter. Wolverine Asset Management LLC increased its position in BlackRock Health Sciences Term Trust by 78.8% during the fourth quarter. Wolverine Asset Management LLC now owns 401,511 shares of the company’s stock worth $6,043,000 after buying an additional 176,993 shares in the last quarter. Finally, Almitas Capital LLC purchased a new position in BlackRock Health Sciences Term Trust during the fourth quarter worth $2,301,000.

BlackRock Health Sciences Term Trust Price Performance

NYSE BMEZ opened at $15.23 on Friday. BlackRock Health Sciences Term Trust has a fifty-two week low of $13.67 and a fifty-two week high of $15.80. The business has a fifty day moving average of $14.69 and a 200-day moving average of $14.72.

BlackRock Health Sciences Term Trust Dividend Announcement

The business also recently disclosed a monthly dividend, which will be paid on Wednesday, September 30th. Investors of record on Tuesday, September 15th will be given a dividend of $0.11 per share. This represents a c) dividend on an annualized basis and a yield of 8.7%. The ex-dividend date is Tuesday, September 15th.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.

The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.